Medexus Pharmaceuticals
Stock Forecast, Prediction & Price Target
Medexus Pharmaceuticals Financial Estimates
Medexus Pharmaceuticals Revenue Estimates
Medexus Pharmaceuticals EBITDA Estimates
Medexus Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 3/31/2021 | 3/31/2022 | 3/31/2024 | 3/31/2026 | 3/31/2027 | 3/31/2028 | 3/31/2029 |
Revenue
% change YoY
| CA$79.66M N/A | CA$76.70M -3.71% | CA$113.05M 47.39% | Avg: CA$114.14M Low: CA$107.78M High: CA$121.89M avg. 0.96% | Avg: CA$124.26M Low: CA$115.48M High: CA$133.20M avg. 8.86% | Avg: CA$201.01M Low: CA$186.80M High: CA$215.47M avg. 61.76% | Avg: CA$265.25M Low: CA$246.50M High: CA$284.32M avg. 31.95% |
Net Income
% change YoY
| CA$-28.26M N/A | CA$-2.87M 89.81% | CA$-214K 92.56% | Avg: CA$12.33M Low: CA$4.49M High: CA$15.39M avg. 5866.33% | Avg: CA$20.12M Low: CA$8.00M High: CA$16.00M avg. 63.12% | Avg: CA$25.30M Low: CA$22.98M High: CA$27.67M avg. 25.72% | Avg: CA$37.96M Low: CA$34.47M High: CA$41.51M avg. 49.99% |
EBITDA
% change YoY
| CA$-23.60M N/A | CA$-6.23M 73.60% | CA$19.27M 409.35% | Avg: CA$5.16M Low: CA$4.87M High: CA$5.51M avg. -73.21% | Avg: CA$5.61M Low: CA$5.22M High: CA$6.02M avg. 8.86% | Avg: CA$9.09M Low: CA$8.44M High: CA$9.74M avg. 61.76% | Avg: CA$11.99M Low: CA$11.14M High: CA$12.85M avg. 31.95% |
EPS
% change YoY
| -$1.86 N/A | -$0.15 91.93% | -$0.01 93.60% | Avg: $0.46 Low: $0.22 High: $0.75 avg. 4854.16% | Avg: $0.63 Low: $0.39 High: $0.78 avg. 37.86% | Avg: $1.23 Low: $1.12 High: $1.35 avg. 95.97% | Avg: $1.85 Low: $1.68 High: $2.02 avg. 49.99% |
Operating Expenses
% change YoY
| CA$41.27M N/A | CA$50.30M 21.87% | CA$48.72M -3.14% | Avg: CA$60.31M Low: CA$56.95M High: CA$64.41M avg. 23.80% | Avg: CA$65.66M Low: CA$61.02M High: CA$70.38M avg. 8.86% | Avg: CA$106.22M Low: CA$98.71M High: CA$113.85M avg. 61.76% | Avg: CA$140.16M Low: CA$130.25M High: CA$150.24M avg. 31.95% |
FAQ
What is Medexus Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 1501.29% in 2026-2029.
We have gathered data from 3 analysts. Their low estimate is 4.49M, average is 12.33M and high is 15.39M.
What is Medexus Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 25.88% in 2026-2029.
We have gathered data from 3 analysts. Their low revenue estimate is CA$107.78M, average is CA$114.14M and high is CA$121.89M.
What is Medexus Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 1259.50% in 2026-2029.
We have gathered data from 3 analysts. Their low earnings per share estimate is $0.22, average is $0.46 and high is CA$0.74.